NewGenIvf Group Ltd (NASDAQ: NIVF)

NewGenIvf Group Ltd (NIVF) operates in the healthcare industry, specifically in the field of fertility services. The company's primary focus is on providing in-vitro fertilization (IVF) treatment services and surrogacy and ancillary caring services. NewGenIvf Group Ltd has a strong presence in the Asia Pacific region, with clinics in Thailand, Cambodia, and Kyrgyzstan.

NewGenIvf Group Ltd generates revenue mainly from its IVF treatment services, which include traditional IVF and egg donation. These services are provided to individuals and couples who are struggling with infertility. The company's range of procedures includes egg retrieval, embryo transfer, and sperm analysis. The surrogacy and ancillary caring services segment is also a significant source of revenue for the company. These services include gestational surrogacy and egg donation, which are provided to individuals and couples seeking to build their families through surrogacy.

The company's experienced medical team, state-of-the-art technology, and reputation for providing high-quality services give it a competitive advantage in the fertility industry. NewGenIvf Group Ltd faces competition from other fertility clinics and surrogacy agencies in the Asia Pacific region.

The company's customers are primarily individuals and couples from the Asia Pacific region who are struggling with infertility and seeking to conceive. NewGenIvf Group Ltd's services are designed to help these individuals and couples build their families through IVF treatment and surrogacy.

NewGenIvf Group Ltd's range of products and services includes traditional IVF, egg donation, gestational surrogacy, and ancillary caring services. The company's brand names and trade names include NewGenIvf and its clinics in Thailand, Cambodia, and Kyrgyzstan.